1
|
Ammar RM, Pferschy-Wenzig EM, Van den Abbeele P, Verstrepen L, Ghyselinck J, Thumann T, Bauer R. Possible role of the gut microbiome in mediating the beneficial effects of the six-herbal formulation STW 5-II on digestive health. Phytomedicine 2023; 119:154996. [PMID: 37595389 DOI: 10.1016/j.phymed.2023.154996] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 07/07/2023] [Accepted: 07/25/2023] [Indexed: 08/20/2023]
Abstract
BACKGROUND STW 5-II is a combination of six herbal extracts with clinically proven efficacy in functional dyspepsia (FD) and irritable bowel syndrome (IBS). STW 5-II contains a wide variety of secondary plant constituents that may interact with the human gut microbiome. In addition to complex carbohydrates, secondary plant metabolites, such as polyphenols, are known to exert prebiotic-like effects. PURPOSE This study aimed to assess the bidirectional interactions between STW 5-II and the human gut microbiome. METHODS STW 5-II was incubated with human fecal microbiota in a short-term colonic model. In the samples, the impact of STW 5-II on microbial fermentation capacity (pH, gas production), short chain fatty acid (SCFA) production, and microbial composition (Illumina 16S rRNA gene sequencing) was analyzed. In addition, the biotransformation of STW 5-II constituents by the fecal microbiota was assessed by UHPLCHRMS-based metabolite profiling. Furthermore, Caco-2/THP1 co-culture assay was used to explore the effect on gut barrier integrity and inflammatory markers. RESULTS Fermentation of STW 5-II by fecal microbiota led to consistent changes in pH and gas production and increased production of SCFAs (acetate, propionate, and butyrate). STW 5-II promoted the enrichment of Bifidobacteriaceae, Lachnospiraceae, Ruminococcaceae, Erysipelotrichaceae, and Eggerthellaceae and suppressed the growth of pathogenic species from the Enterobacteriaceae family. In Caco2/THP1 culture, treatment with STW 5-II-incubated samples resulted in significantly increased transepithelial electrical resistance, indicating enhanced barrier function. Among inflammatory markers, STW 5-II-incubated samples increased LPS-induced secretion of the anti-inflammatory cytokine IL-10, as well as NF-κB activity, and significantly decreased the secretion of the pro-inflammatory chemokine MCP-1. UHPLCHRMS analysis identified 110 constituents of STW 5-II with changed levels during incubation with fecal microbiota: 63 constituents that were metabolized, 22 intermittently increased metabolites, and 25 final metabolites, including compounds with established anti-inflammatory activity, such as 18β-glycyrrhetinic acid. CONCLUSION These findings indicate a microbiome-mediated digestive health-promoting effect of STW 5-II via three different routes, namely enhanced microbial SCFA production, microbial production of potentially bioactive metabolites from STW 5-II constituents, and prebiotic-like action by promoting the proliferation/growth of beneficial bacteria.
Collapse
Affiliation(s)
- R M Ammar
- Bayer Consumer Health, Steigerwald Arzneimittelwerk GmbH, Havelstraße 5, 64295 Darmstadt, Germany; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafr-El Sheikh 33516, Egypt
| | - E M Pferschy-Wenzig
- Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Beethovenstrasse 8, 8010 Graz, Austria; BioTechMed, Mozartgasse 12, 8010 Graz, Austria
| | | | - L Verstrepen
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium
| | - J Ghyselinck
- ProDigest BV, Technologiepark 82, 9052 Ghent, Belgium
| | - T Thumann
- Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Beethovenstrasse 8, 8010 Graz, Austria; BioTechMed, Mozartgasse 12, 8010 Graz, Austria
| | - R Bauer
- Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Beethovenstrasse 8, 8010 Graz, Austria; BioTechMed, Mozartgasse 12, 8010 Graz, Austria.
| |
Collapse
|
2
|
Reese L, Haenschke L, Niepmann ST, Bulic M, Duesing P, Zimmer S, Nickenig G, Bauer R, Jansen F, Zietzer A. Loss of ceramide synthase 5 reduces the development of aortic valve stenosis in mice with high fat diet. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.2998] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Ceramide synthase 5 (CerS5) is essential to maintain C:16 ceramide levels in mice. Ceramides contribute to inflammation and calcification, two hallmarks of aortic valve stenosis development. It is known, that loss of CerS5 function reduces diet-induced obesity.
Purpose
The aim of this study was to investigate the effect of ceramide synthase 5 and high-fat diet on the development of aortic valve stenosis with a mouse model.
Methods
Our experiment consists of four groups of mice: Wild type (WT) and CerS5 (−/−) mice, with normal and high fat diet. We induced the aortic valve stenosis development through a wire-injury. For this model, a coronary angiography wire is introduced into the left ventricle over the right carotid artery, followed by rotation on the aortic valve level to generate a defined injury. Development of aortic valve stenosis was determined by measuring the peak velocity 14, 28 and 42 days after the wire-injury. With histological analysis of the aortic valve, we measured macrophage infiltration with CD68 immunostaining and calcification using von Kossa staining. For statistical analysis ANOVA and Turkeys multiple comparisons were performed.
Results
Histological analysis of the aortic valve revealed, that in CerS5 (−/−) mice with high fat diet (HFD) immune cell infiltration is reduced, while there is no difference between CerS5 (−/−) mice and wild type, when fed with normal diet (A). Also calcification showed a trend towards a reduction in CerS5 mice with high fat diet, but was not statistically significant (B). Echocardiography could detect a reduced peak velocity of CerS5 mice with high fat diet, in comparison to the other groups, four and six weeks after wire injury (C).
Conclusion
Our experiments indicate that loss of CerS5 function reduces the development of aortic valve stenosis in mice with high fat diet, by decreasing immune cell infiltration and calcification. Interestingly, in the groups with normal chow, loss of CerS5 function had no effect. In addition, high-fat diet alone had no negative effect in our mouse model. Based on our results it can be assumed that upon high fat diet CerS5 mediates for pro-inflammatory effects in the aortic valve, which are absent on normal diet.
Funding Acknowledgement
Type of funding sources: Foundation. Main funding source(s): Ernst & Berta Grimmke Foundation (13/19)
Collapse
Affiliation(s)
- L Reese
- University Hospital Bonn , Bonn , Germany
| | - L Haenschke
- LIMES-Life & Medical Sciences Institute, Developmental Genetics & Molecular Physiology , Bonn , Germany
| | | | - M Bulic
- University Hospital Bonn , Bonn , Germany
| | - P Duesing
- University Hospital Bonn , Bonn , Germany
| | - S Zimmer
- University Hospital Bonn , Bonn , Germany
| | - G Nickenig
- University Hospital Bonn , Bonn , Germany
| | - R Bauer
- LIMES-Life & Medical Sciences Institute, Developmental Genetics & Molecular Physiology , Bonn , Germany
| | - F Jansen
- University Hospital Bonn , Bonn , Germany
| | - A Zietzer
- University Hospital Bonn , Bonn , Germany
| |
Collapse
|
3
|
Lohberger B, Kaltenegger H, Eck N, Glänzer D, Leithner A, Bauer R, Kretschmer N, Steinecker-Frohnwieser B. AB0048 THE SUPPRESSION OF INFLAMMATORY PROCESSES AND MODULATION OF MAPK SIGNALING BY SHIKONIN DERIVATIVES IN PRIMARY OA CHONDROCYTES. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.1544] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundOsteoarthritis (OA) is one of the most common joint disorders and is characterized by the degeneration and loss of articular cartilage with chronic arthritis of the joint edge and subchondral bone. OA is causally influenced by several factors, including age, gender, familial susceptibility, as well as local biomechanics, cartilage cell apoptosis, and the action of degenerative enzymes. Despite intensive research, there are still few effective therapeutic approaches.ObjectivesIn the rat OA model, shikonin was shown to inhibit inflammatory processes and chondrocyte apoptosis by regulating the PI3K/AKT pathway. Therefore, we investigated the effect of shikonin and its derivatives acetylshikonin and cyclopropylshikonin on inflammation, MMP expression, and regulation of MAPK signaling in human OA chondrocytes.MethodsViability was analyzed using the CellTiter 96 AQueous Luminescence Assay on human healthy chondrocytes (HC) and primary OA chondrocytes (pCH-OA). For the study of inflammatory processes, we performed a proteome profile screening assay. As MAPK signaling pathways play a key role in cartilage destruction in OA, we analyzed the effects of shikonin and its derivatives using protein expression analysis of the phosphorylation pattern and the corresponding downstream gene regulation using RT-qPCR.ResultsBoth HC and pCH-OA showed a dose-dependent inhibition of cell viability after treatment with shikonin derivatives, whereby the strongest effects were found for shikonin with IC50 values of 1.2 µM and 1.3 µM, respectively. Shikonin counteracts inflammatory response caused by IL-1β by massively reducing the expression of pro-inflammatory mediators.Phosphorylation level of ERK changed slightly, pJNK and pp38 showed a significant increase after treatment with the shikonin derivatives both in HC and pCH-OA cells. The downstream targets c/EBPs and MEF2c may play a role in the homeostasis of joint cartilage under physiological and pathological conditions. The phosphorylation level of STAT3 significantly decreased in a dose-dependent manner after treatment. STAT3 blockade has a chondroprotective function through a regulation of cyclin D1 or Sox9.ConclusionOur results demonstrate for the first time that shikonin and its derivatives acetylshikonin and cyclopropylshikonin have extensive effects on inflammatory processes, MAPKs, and IL6/STAT3 downstream regulation in human healthy chondrocytes and primary OA chondrocytes.ReferencesnoneDisclosure of InterestsNone declared
Collapse
|
4
|
Singerer I, Gruen K, Schrepper A, Baez L, Schwarzer M, Bauer R, Jung C, Berndt A, Schulze PC, Franz M. Crucial role of extra-domain A containing fibronectin for the development of pulmonary hypertension and associated right heart failure. Eur Heart J 2021. [DOI: 10.1093/eurheartj/ehab724.3420] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Pulmonary vascular and right ventricular myocardial remodelling are unique phenomena in PH progression. Both processes are accompanied by an abundant re-expression of the extra-domain A of fibronectin (ED-A+ Fn) therefore qualifying as promising biomarker or even therapeutic target. Nevertheless, its functional role in PH pathogenesis remains unclear until now. Objective: The purpose of our study was to analyse the development of PH and RHF in a mouse model of monocrotaline (MCT)-induced PH comparing C57BL/6 ED-A+ Fn knockout (KO) and wild-type (WT) mice.
Methods
PH was induced by subcutaneous injection of a single dose of MCT (60 mg/kg body weight). Subgroups were additionally treated with the dual endothelin receptor antagonist Macitentan (MAC, 15mg/kg body weight per day from day 14 to 28). There were 6 experimental groups: sham-treated control WT mice (WTco, n=4); MCT induced PH WT mice (WTPH, n=6); MCT induced PH WT mice treated with MAC (WTPH_MAC, n=6); sham-treated control KO mice (KOco, n=4); MCT induced PH KO mice (KOPH, n=6); MCT induced PH KO mice treated with MAC (KOPH_MAC, n=6). Between day 26 and 28, transthoracic echocardiography and right heart catheterization were performed. Both, lung and cardiac tissue samples were subjected to histological analyses.
Results
Right heart catheterization revealed significantly increased RVPsys values in WTPH (87.0±16.4mmHg) compared to WTco (36.1±9.4mmHg; p=0.034) animals, which showed, at least in trend, a diminution in the WTPH_MAC group (67.1±20.9mmHg; p=n.s.). There was a non-significant increase in RVPsys in the KOPH (55.6±14.9mmHg) compared to KOco mice (37.2±5.6mmHg; p=n.s.) without any differences compared to the KOPH_MAC group (60.9±14.0mmHg; p=n.s.). When comparing the WTPH and the KOPH group, RVPsys was significantly lower in the KO animals (p=0.014), while there were no differences between the WTPH_MAC and the KOPH_MAC group (p=n.s.). Echocardiographic evaluation including surrogate parameters of right ventricular (RV) overload and failure were significantly altered in WTPH compared to WTco animals (p<0.05) and could not be shown to be relevantly improved in the WTPH_MAC group (p=n.s.). The majority of echocardiographic parameters did not significantly differ between the KOPH and the KOco group (p=n.s.). Lung tissue analysis revealed significant alterations in both, the WTPH and the KOPH group, each compared to the corresponding control (p<0.05). The level of lung tissue damage was significantly decreased in KOPH compared to WTPH mice (p<0.05). In RV, the amount of interstitial fibrosis was increased in the WTPH (p=0.009) but not in the KOPH group (p=n.s.), each compared to the corresponding controls.
Conclusions
The findings of the current study underline the hypothesis that ED-A+ Fn is a key player in the pathogenesis of PH and associated RHF. Thus, it might represent a promising therapeutic target, e.g., by the administration of neutralizing antibodies.
Funding Acknowledgement
Type of funding sources: Public hospital(s). Main funding source(s): University Hospital Jena
Collapse
Affiliation(s)
- I Singerer
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - K Gruen
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - A Schrepper
- University Hospital Jena, Department of Cardiothoracic Surgery, Jena, Germany
| | - L Baez
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - M Schwarzer
- University Hospital Jena, Department of Cardiothoracic Surgery, Jena, Germany
| | - R Bauer
- University Hospital Jena, Institute of Molecular Cell Biology, Jena, Germany
| | - C Jung
- Heinrich-Heine-University, Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Germany
| | - A Berndt
- University Hospital of Jena, Institut of Legal Medicine, Section of Pathology, Jena, Germany
| | - P C Schulze
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - M Franz
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| |
Collapse
|
5
|
Leitzke M, Schimpf S, Altrock M, Schönknecht P, Bischoff S, Schubert H, Hoyer D, Bauer R, Olbrich S. Afferent vagal stimulation via gastric electrical stimulation alters sympathetic-vagal balance in domestic pigs - a pilot trial. J BIOL REG HOMEOS AG 2021; 35:11-24. [PMID: 33474908 DOI: 10.23812/20-527-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
The disturbance of the sympathetic-vagal balance with increasing sympathetic activity and consecutive increase in cytokine release is a major threat in numerous hyperinflammatory syndromes. Therapeutic interventions that modulate the activity in the sympathetic-vagal system are suggested as an effective treatment in these incidences. The purpose of this pilot study was to investigate the effect of electrical stimulation of the gastric wall on sympathetic-vagal balance. German domestic pigs (n=5) were prepared with a modified gastric tube (mGT) for repetitive gastric electrical stimulation (GES). Electrocardiogram was recorded continuously and heart rate variability (HRV) as measure of sympathetic-vagal activity was calculated for three-minute epochs at baseline condition before GES and during GES condition. In comparison to baseline, activity of the autonomic nervous system (ANS) shifted significantly toward increased dominance of vagal activity during GES with a decrease of normalized low frequency (nLF from 58.00 to 25.52) as marker of sympathetic dominance and parallel increase of normalized high frequency (nHF from 41.48 to 74.16) as marker of vagal dominance. During GES, compared to baseline, no difference in heart rate was found. These results indicate that electrical stimulation of the gastric wall may result in shifting the sympathetic-vagal balance toward a parasympathetic predominance.
Collapse
Affiliation(s)
- M Leitzke
- Helios Clinics, Department of Anaesthesiology, Leisnig, Germany
| | - S Schimpf
- Dräger Medical GmbH, Lübeck, Germany
| | - M Altrock
- MTU Reman Technologies GmbH, Magdeburg, Germany
| | - P Schönknecht
- Leipzig University, Medical faculty, Saxon hospital, Arnsdorf, Germany
| | - S Bischoff
- University of Jena, Institute for animal testing, experimentation and animal welfare, Jena, Germany
| | - H Schubert
- University of Jena, Institute for animal testing, experimentation and animal welfare, Jena, Germany
| | - D Hoyer
- University of Jena, Hans Berger Department of Neurology, Jena, Germany
| | - R Bauer
- University of Jena, Institute for molecular cell biology, Jena, Germany
| | - S Olbrich
- University of Zurich, Department of Psychiatry, Zürich, Switzerland
| |
Collapse
|
6
|
Schmidt D, Bauer R, Chung S, Novikov D, Sander M, Pudell JE, Herzog M, Pfuetzenreuter D, Schwarzkopf J, Chernikov R, Gaal P. A new concept for temporal gating of synchrotron X-ray pulses. J Synchrotron Radiat 2021; 28:375-382. [PMID: 33650548 PMCID: PMC7941288 DOI: 10.1107/s1600577521000151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 01/05/2021] [Indexed: 06/12/2023]
Abstract
A new concept for temporal gating of synchrotron X-ray pulses based on laser-induced thermal transient gratings is presented. First experimental tests of the concept yield a diffraction efficiency of 0.18%; however, the calculations indicate a theoretical efficiency and contrast of >30% and 10-5, respectively. The full efficiency of the pulse picker has not been reached yet due to a long-range thermal deformation of the sample after absorption of the excitation laser. This method can be implemented in a broad spectral range (100 eV to 20 keV) and is only minimally invasive to an existing setup.
Collapse
Affiliation(s)
- D. Schmidt
- Institut für Nanostruktur- und Festkörperphysik, Universität Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - R. Bauer
- Institut für Nanostruktur- und Festkörperphysik, Universität Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany
| | - S. Chung
- Deutsches Elektronen-Synchrotron (DESY), 22607 Hamburg, Germany
| | - D. Novikov
- Deutsches Elektronen-Synchrotron (DESY), 22607 Hamburg, Germany
| | - M. Sander
- Paul-Scherrer Institute, Forschungsstrasse 111, 5232 Villigen, Switzerland
| | - J.-E. Pudell
- Institut für Physik und Astronomie, Universität Potsdam, 14476 Potsdam, Germany
| | - M. Herzog
- Institut für Physik und Astronomie, Universität Potsdam, 14476 Potsdam, Germany
| | - D. Pfuetzenreuter
- Leibniz-Institut für Kristallzüchtung, Max-Born-Strasse 2, 12489 Berlin, Germany
| | - J. Schwarzkopf
- Leibniz-Institut für Kristallzüchtung, Max-Born-Strasse 2, 12489 Berlin, Germany
| | - R. Chernikov
- Canadian Light Source Inc., 44 Innovation Boulevard, Saskatoon, Canada SK S7N 2V3
| | - P. Gaal
- Institut für Nanostruktur- und Festkörperphysik, Universität Hamburg, Luruper Chaussee 149, 22761 Hamburg, Germany
- Leibniz-Institut für Kristallzüchtung, Max-Born-Strasse 2, 12489 Berlin, Germany
| |
Collapse
|
7
|
Bauer R, Tse JS, Komatsu K, Machida S, Hattori T. Slow compression of crystalline ice at low temperature. Nature 2020; 585:E9-E10. [PMID: 32939064 DOI: 10.1038/s41586-020-2697-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2019] [Accepted: 08/10/2020] [Indexed: 11/09/2022]
Affiliation(s)
- R Bauer
- Department of Physics and Engineering Physics, University of Saskatchewan, Saskatchewan, Saskatoon, Canada
| | - J S Tse
- Department of Physics and Engineering Physics, University of Saskatchewan, Saskatchewan, Saskatoon, Canada.
| | - K Komatsu
- Geochemical Research Center (GCRC), Graduate School of Science, The University of Tokyo, Tokyo, Japan
| | - S Machida
- Neutron Science and Technology Center, CROSS, Tokai, Japan
| | - T Hattori
- J-PARC Center, Japan Atomic Energy Agency, Naka-gun, Japan
| |
Collapse
|
8
|
Bauer M, Glenn T, Alda M, Andreassen O, Angelopoulos E, Ardau R, Baethge C, Bauer R, Bellivier F, Belmaker R, Berk M, Bjella T, Bossini L, Bersudsky Y, Cheung E, Conell J, Del Zompo M, Dodd S, Etain B, Fagiolini A, Frye M, Fountoulakis K, Garneau-Fournier J, Gonzalez-Pinto A, Harima H, Hassel S, Henry C, Iacovides A, Isometsä E, Kapczinski F, Kliwicki S, König B, Krogh R, Kunz M, Lafer B, Larsen E, Lewitzka U, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Monteith S, Morken G, Munoz R, Nery F, O’Donovan C, Osher Y, Pfennig A, Quiroz D, Ramesar R, Rasgon N, Reif A, Ritter P, Rybakowski J, Sagduyu K, Scippa A, Severus E, Simhandl C, Stein D, Strejilevich S, Hatim Sulaiman A, Suominen K, Tagata H, Tatebayashi Y, Torrent C, Vieta E, Viswanath B, Wanchoo M, Zetin M, Whybrow P. Influence of birth cohort on age of onset cluster analysis in bipolar I disorder. Eur Psychiatry 2020; 30:99-105. [DOI: 10.1016/j.eurpsy.2014.10.005] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/02/2014] [Revised: 09/10/2014] [Accepted: 10/21/2014] [Indexed: 10/24/2022] Open
Abstract
AbstractPurpose:Two common approaches to identify subgroups of patients with bipolar disorder are clustering methodology (mixture analysis) based on the age of onset, and a birth cohort analysis. This study investigates if a birth cohort effect will influence the results of clustering on the age of onset, using a large, international database.Methods:The database includes 4037 patients with a diagnosis of bipolar I disorder, previously collected at 36 collection sites in 23 countries. Generalized estimating equations (GEE) were used to adjust the data for country median age, and in some models, birth cohort. Model-based clustering (mixture analysis) was then performed on the age of onset data using the residuals. Clinical variables in subgroups were compared.Results:There was a strong birth cohort effect. Without adjusting for the birth cohort, three subgroups were found by clustering. After adjusting for the birth cohort or when considering only those born after 1959, two subgroups were found. With results of either two or three subgroups, the youngest subgroup was more likely to have a family history of mood disorders and a first episode with depressed polarity. However, without adjusting for birth cohort (three subgroups), family history and polarity of the first episode could not be distinguished between the middle and oldest subgroups.Conclusion:These results using international data confirm prior findings using single country data, that there are subgroups of bipolar I disorder based on the age of onset, and that there is a birth cohort effect. Including the birth cohort adjustment altered the number and characteristics of subgroups detected when clustering by age of onset. Further investigation is needed to determine if combining both approaches will identify subgroups that are more useful for research.
Collapse
|
9
|
Bauer M, Glenn T, Alda M, Bauer R, Grof P, Marsh W, Monteith S, Munoz R, Rasgon N, Sagduyu K, Whybrow PC. Trajectories of adherence to mood stabilizers in patients with bipolar disorder. Int J Bipolar Disord 2019; 7:19. [PMID: 31482209 PMCID: PMC6722168 DOI: 10.1186/s40345-019-0154-z] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2019] [Accepted: 07/24/2019] [Indexed: 01/27/2023] Open
Abstract
Background Nonadherence with mood stabilizers is a major problem that negatively impacts the course of bipolar disorder. Medication adherence is a complex individual behavior, and adherence rates often change over time. This study asked if distinct classes of adherence trajectories with mood stabilizers over time could be found, and if so, which patient characteristics were associated with the classes. Methods This analysis was based on 12 weeks of daily self-reported data from 273 patients with bipolar 1 or II disorder using ChronoRecord computer software. All patients were taking at least one mood stabilizer. The latent class mixed model was used to detect trajectories of adherence based on 12 weekly calculated adherence datapoints per patient. Results Two distinct trajectory classes were found: an adherent class (210 patients; 77%) and a less adherent class (63 patients; 23%). The characteristics associated with the less adherent class were: more time not euthymic (p < 0.001) and female gender (p = 0.016). No other demographic associations were found. Conclusion In a sample of motivated patients who complete daily mood charting, about one quarter were in the less adherent class. Even patients who actively participate in their care, such as by daily mood charting, may be nonadherent. Demographic characteristics may not be useful in assessing individual adherence. Future research on longitudinal adherence patterns in bipolar disorder is needed.
Collapse
Affiliation(s)
- M Bauer
- Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
| | - T Glenn
- ChronoRecord Association Inc., Fullerton, CA, USA
| | - M Alda
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
| | - R Bauer
- Department of Psychiatry and Psychotherapy, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany
| | - P Grof
- Mood Disorders Center of Ottawa, University of Toronto, Toronto, Canada
| | - W Marsh
- Department of Psychiatry, University of Massachusetts, Worcester, MA, USA
| | - S Monteith
- Michigan State University College of Human Medicine, Traverse City Campus, Traverse City, MI, USA
| | - R Munoz
- Department of Psychiatry, University of California San Diego, San Diego, CA, USA
| | - N Rasgon
- Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Palo Alto, CA, USA
| | - K Sagduyu
- Department of Psychiatry, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
| | - P C Whybrow
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior University of California Los Angeles (UCLA), Los Angeles, CA, USA
| |
Collapse
|
10
|
Pérez K, Weijermars W, Bos N, Filtness AJ, Bauer R, Johannsen H, Nuyttens N, Pascal L, Thomas P, Olabarria M. Implications of estimating road traffic serious injuries from hospital data. Accid Anal Prev 2019; 130:125-135. [PMID: 29680154 DOI: 10.1016/j.aap.2018.04.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/29/2016] [Revised: 04/02/2018] [Accepted: 04/06/2018] [Indexed: 06/08/2023]
Abstract
To determine accurately the number of serious injuries at EU level and to compare serious injury rates between different countries it is essential to use a common definition. In January 2013, the High Level Group on Road Safety established the definition of serious injuries as patients with an injury level of MAIS3+(Maximum Abbreviated Injury Scale). Whatever the method used for estimating the number or serious injuries, at some point it is always necessary to use hospital records. The aim of this paper is to understand the implications for (1) in/exclusion criteria applied to case selection and (2) a methodological approach for converting ICD (International Classification of Diseases/Injuries) to MAIS codes, when estimating the number of road traffic serious injuries from hospital data. A descriptive analysis with hospital data from Spain and the Netherlands was carried out to examine the effect of certain choices concerning in- and exclusion criteria based on codes of the ICD9-CM and ICD10. The main parameters explored were: deaths before and after 30 days, readmissions, and external injury causes. Additionally, an analysis was done to explore the impact of using different conversion tools to derive MAIS3 + using data from Austria, Belgium, France, Germany, Netherlands, and Spain. Recommendations are given regarding the in/exclusion criteria and when there is incomplete data to ascertain a road injury, weighting factors could be used to correct data deviations and make more real estimations.
Collapse
Affiliation(s)
- K Pérez
- Agència de Salut Pública de Barcelona (ASPB), Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Institut d'Investigació Biomédica (IIB Sant Pau), Spain.
| | - W Weijermars
- Institute for Road Safety Research (SWOV), Netherlands
| | - N Bos
- Institute for Road Safety Research (SWOV), Netherlands
| | - A J Filtness
- Transport Safety Research Centre, Loughborough University (LOUGH), United Kingdom
| | - R Bauer
- Austrian Road Safety Board (KFV), Austria
| | - H Johannsen
- Medical University of Hannover (MHH), Germany
| | | | - L Pascal
- French Institute of Science and Technology for Transport, Development and Networks (IFSTTAR), France
| | - P Thomas
- Transport Safety Research Centre, Loughborough University (LOUGH), United Kingdom
| | - M Olabarria
- Agència de Salut Pública de Barcelona (ASPB), Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain; Institut d'Investigació Biomédica (IIB Sant Pau), Spain
| |
Collapse
|
11
|
Oberwinkler F, Bandoni RJ, Bauer R, Deml G, Kisimova-Horovitz L. The Life-History ofChristiansenia Pallida, A Dimorphic, Mycoparasitic Heterobasidiomycete. Mycologia 2018. [DOI: 10.1080/00275514.1984.12023804] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- F. Oberwinkler
- Lehrstuhl Spezielle Botanik, Universität Tübingen, Auf der Morgenstelle 1, D-7400 Tübingen, Germany
| | - R. J. Bandoni
- Department of Botany, University of British Columbia, Vancouver, B.C., Canada V6T 2B1
| | - R. Bauer
- Lehrstuhl Spezielle Botanik, Universität Tübingen, Auf der Morgenstelle 1, D-7400 Tübingen, Germany
| | - G. Deml
- Lehrstuhl Spezielle Botanik, Universität Tübingen, Auf der Morgenstelle 1, D-7400 Tübingen, Germany
| | - L. Kisimova-Horovitz
- Lehrstuhl Spezielle Botanik, Universität Tübingen, Auf der Morgenstelle 1, D-7400 Tübingen, Germany
| |
Collapse
|
12
|
Johnston JM, Angyal A, Bauer R, Hamby SE, Suvarna SK, Baidžajevas K, Hegedus Z, Dear NT, Turner M, Wilson HL, Goodall AH, Rader DJ, Shoulders CC, Francis SE, Kiss-Toth E. P14 MYELOID TRIB1 PROMOTES EXPERIMENTAL ATHEROSCLEROSIS. Cardiovasc Res 2018. [DOI: 10.1093/cvr/cvy216.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- J M Johnston
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - A Angyal
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - R Bauer
- Division of Cardiology, Dept. of Medicine, Columbia University Medical Center, USA
- Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia, Smilow Center for Translational Research, Philadelphia, USA
| | - S E Hamby
- Department of Cardiovascular Sciences, University of Leicester and NIHR Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK
| | - S K Suvarna
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - K Baidžajevas
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - Z Hegedus
- Institute of Biophysics, Biological Research Centre, Hungarian Academy of Sciences, Szeged & Departments of Biochemistry and Medicinal Chemistry, University of Pecs, Medical School, Hungary
| | - N T Dear
- Department of Medicine, University of Leeds, UK
| | - M Turner
- Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge, UK
| | - H L Wilson
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - A H Goodall
- Department of Cardiovascular Sciences, University of Leicester and NIHR Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK
| | - D J Rader
- Perelman School of Medicine at the University of Pennsylvania and Children’s Hospital of Philadelphia, Smilow Center for Translational Research, Philadelphia, USA
| | - C C Shoulders
- Centre for Endocrinology, William Harvey Institute, Queen Mary University of London, UK
| | - S E Francis
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | - E Kiss-Toth
- Department of Infection, Immunity & Cardiovascular Disease, Medical School, Beech Hill Road, University of Sheffield, UK
| | | |
Collapse
|
13
|
Affiliation(s)
- A. Nagler
- Institut für Biologie 1, Lehrstuhl Spezielle Botanik/Mykologie, Auf der Morgenstelle 1, D-7400 Tübingen, BRD
| | - R. Bauer
- Institut für Biologie 1, Lehrstuhl Spezielle Botanik/Mykologie, Auf der Morgenstelle 1, D-7400 Tübingen, BRD
| | - M. Berbee
- Institut für Biologie 1, Lehrstuhl Spezielle Botanik/Mykologie, Auf der Morgenstelle 1, D-7400 Tübingen, BRD
| | - K. Vánky
- Institut für Biologie 1, Lehrstuhl Spezielle Botanik/Mykologie, Auf der Morgenstelle 1, D-7400 Tübingen, BRD
| | - F. Oberwinkler
- Institut für Biologie 1, Lehrstuhl Spezielle Botanik/Mykologie, Auf der Morgenstelle 1, D-7400 Tübingen, BRD
| |
Collapse
|
14
|
Affiliation(s)
- K. Vánky
- Universität Tübingen, Botanisches Institut, Spezielle Botanik und Mykologie, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| | - R. Bauer
- Universität Tübingen, Botanisches Institut, Spezielle Botanik und Mykologie, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| | - D. Begerow
- Universität Tübingen, Botanisches Institut, Spezielle Botanik und Mykologie, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| |
Collapse
|
15
|
Sachdev V, Leopold C, Bauer R, Patankar J, Iqbal J, Obrowsky S, Doktorova M, Scheicher B, Goeritzer M, Kolb D, Turnbull A, Zimmer A, Hoefler G, Hussain M, Groen A, Kratky D. Novel role of a triglyceride-synthesizing enzyme: DGAT1 at the crossroad between triglyceride and cholesterol metabolism. Atherosclerosis 2018. [DOI: 10.1016/j.atherosclerosis.2018.06.915] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
16
|
Rohm I, Gruen K, Foerster M, Fritzenwanger M, Bauer R, Yilmaz A, Pistulli R, Jung C, Berndt A, Schulze PC, Franz M. P3791Right ventricular remodelling and inflammation in monocrotaline-induced pulmonary hypertension: effects of the endothelin receptor antagonist macitentan. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy563.p3791] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- I Rohm
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - K Gruen
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - M Foerster
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - M Fritzenwanger
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - R Bauer
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - A Yilmaz
- Elisabeth-Klinikum, Department of Internal Medicine I, Schmalkalden, Germany
| | - R Pistulli
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - C Jung
- Heinrich-Heine-University, Department of Internal Medicine, Division of Cardiology, Pulmonology and Vascular Medicine, Düsseldorf, Germany
| | - A Berndt
- University Hospital Jena, Institute of Pathology, Jena, Germany
| | - P C Schulze
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| | - M Franz
- University Hospital Jena, Department of Internal Medicine I, Jena, Germany
| |
Collapse
|
17
|
Chas J, Bauer R, Roux P, Cua E, Cotte L, Capitant C, Hall N, Pialoux G, Molina J, Alvarez J. Évaluation par analyse capillaire de la consommation de drogues parmi les HSH dans l’essai de PreP ANRS-Ipergay. Med Mal Infect 2018. [DOI: 10.1016/j.medmal.2018.04.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
18
|
Bauer R, Zoellner I. Vergleich der Sterblichkeit in Baden-Württemberg von 2004 und 2010 getrennt nach Alter und Geschlecht. Das Gesundheitswesen 2018. [DOI: 10.1055/s-0038-1639243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- R Bauer
- Landesgesundheitsamt BW, Gesundheitsschutz und Epidemiologie, Stuttgart, Germany
| | - I Zoellner
- Landesgesundheitsamt BW, Gesundheitsschutz und Epidemiologie, Stuttgart, Germany
| |
Collapse
|
19
|
Bauer R, Mauerer S, Grempels A, Spellerberg B. The competence system of Streptococcus anginosus and its use for genetic engineering. Mol Oral Microbiol 2018; 33:194-202. [PMID: 29290101 DOI: 10.1111/omi.12213] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/23/2017] [Indexed: 11/30/2022]
Abstract
Streptococcus anginosus is considered a human commensal but improvements in species identification in recent years have highlighted its role as an emerging pathogen. However, our knowledge about the pathogenicity mechanisms in this species is scarce. One reason for this is the lack of published genetic manipulation techniques in the S. anginosus group. To establish a novel mutation technique we investigated the competence system of S. anginosus and created a Cre-recombinase-based mutation method that allows the generation of markerless gene deletions in S. anginosus. In silico analysis of the competence system demonstrated that S. anginosus encodes homologues for the vast majority of genes that are known to be essential for the transformation of S. pneumoniae. Analysis of transformation kinetics confirmed that S. anginosus SK52 possesses an S. pneumoniae-like competence development with a rapid increase of competence after treatment with Competence Stimulating Peptide (CSP), reaching a maximum transformation efficiency of 0.24% ± 0.08%. The combination of CSP-induced transformation and the Cre-lox system allows the efficient and fast creation of markerless gene deletions and will facilitate the investigation of the pathogenicity of S. anginosus on a genetic level.
Collapse
Affiliation(s)
- R Bauer
- Institute of Medical Microbiology and Hospital Hygiene, University of Ulm, Ulm, Germany
| | - S Mauerer
- Institute of Medical Microbiology and Hospital Hygiene, University of Ulm, Ulm, Germany
| | - A Grempels
- Institute of Medical Microbiology and Hospital Hygiene, University of Ulm, Ulm, Germany
| | - B Spellerberg
- Institute of Medical Microbiology and Hospital Hygiene, University of Ulm, Ulm, Germany
| |
Collapse
|
20
|
Abstract
Zusammenfassung
Ziel: Die Indikation zur Radiojodtherapie unifokaler autonomer Adenome wurde bisher meist nur dann gestellt, wenn das Adenomvolumen >8 ml oder der Tc-Uptake unter Suppressionsbedingungen >2% waren. Wir haben untersucht, inwieweit bei thyreogenen Beschwerden die Indikation erweitert werden kann. Methode: Im Zeitraum von März 1993 bis April 1994 wurden 11 Patienten einer Radiojodtherapie unterzogen, bei denen das Adenomvolumen unter 8 ml lag und der Tc-Uptake unter Suppression kleiner als 2% war. Ergebnis: Bei allen 11 Patienten waren die thyreogenen Beschwerden nach der Radiojodtherapie deutlich gebessert. Schlußfolgerung: Wir halten es für sinnvoll, die Indikation zur Radiojodtherapie bei kleinen unifokalen Adenomen zu erweitern.
Collapse
|
21
|
Kehrer A, Engelmann S, Bauer R, Taeger C, Grechenig S, Kehrer M, Prantl L, Tamm ER, Bleys RLAW, Mandlik V. The nerve supply of zygomaticus major: Variability and distinguishing zygomatic from buccal facial nerve branches. Clin Anat 2018; 31:560-565. [PMID: 29322603 DOI: 10.1002/ca.23044] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/19/2017] [Revised: 12/14/2017] [Accepted: 01/08/2018] [Indexed: 11/11/2022]
Abstract
The zygomaticus major (ZM) is important for the human smile. There are conflicting data about whether the zygomatic or buccal branches of the facial nerve are responsible for its motor innervation. The literature provides no precise distinction of the transition zone between these two branch systems. In this study, a definition to distinguish the facial nerve branches at the level of the body of the zygoma is proposed. In the light of this definition, we conducted an anatomical study to determine how the source of innervation of the ZM was distributed. A total of 96 fresh-frozen cadaveric facial halves were dissected under loupe magnification. A hemiparotidectomy was followed by antegrade microsurgical dissection. Any branch topographically lying superficial to the zygoma or touching it was classed as zygomatic, and any neighboring inferior branch was considered buccal. The arborization of the facial nerve was diffuse in all cases. In 64 out of 96 specimens (67%, 95% CI: 56% to 76%), zygomatic branches innervated the ZM. Buccal branches innervated ZM in the other 32 facial halves (33%, 95% CI: 24% to 44%). There were no differences in respect of sex or facial side. All facial halves displayed additional branches, which crossed the muscle on its inner surface without supplying it. In 31 specimens, a nerve branch ran superficial to ZM in its cranial third. According to our classification, the zygomaticus major is innervated by zygomatic branches in 67% of cases and by buccal branches in 33%. Clin. Anat. 31:560-565, 2018. © 2018 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- A Kehrer
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| | - S Engelmann
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| | - R Bauer
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| | - C Taeger
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| | - S Grechenig
- Department of Trauma Surgery, University Hospital Regensburg, Germany
| | - M Kehrer
- Department of Trauma Surgery, University Hospital Bonn, Germany
| | - L Prantl
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| | - E R Tamm
- Institute of Human Anatomy, University of Regensburg, Germany
| | - R L A W Bleys
- Department of Anatomy, University Medical Center Utrecht, The Netherlands
| | - V Mandlik
- Department of Plastic, Reconstructive and Hand Surgery, University Hospital Regensburg, Germany
| |
Collapse
|
22
|
Schwab DM, Tilemann L, Bauer R, Heckmann M, Jungmann A, Wagner M, Burgis J, Vettel C, Katus HA, El-Armouche A, Müller OJ. AAV-9 mediated phosphatase-1 inhibitor-1 overexpression improves cardiac contractility in unchallenged mice but is deleterious in pressure-overload. Gene Ther 2018; 25:13-19. [DOI: 10.1038/gt.2017.97] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2017] [Revised: 10/16/2017] [Accepted: 11/20/2017] [Indexed: 11/09/2022]
|
23
|
Abstract
SummaryAim: Establishment of radioiodine treatment of feline hyperthyroidism in veterinary routine in accordance with German radiation protection regulations. Patients and methods: 35 cats with proven hyperthyroidism were treated with 131I in a special ward. Thyroid uptake and effective halflife were determined using gammacamera dosimetry. Patients were released when measured whole body activity was below the limit defined in the German “Strahlenschutzverordnung”. Results: 17/20 cats treated with 150 MBq radioiodine and 15/15 cats treated with 250 MBq had normal thyroid function after therapy, normal values for FT3 and FT4 were reached after two and normal TSH levels after three weeks. In 14 cats normal thyroid function was confirmed by controls 3-6 months later. Thyroidal iodine uptake was 24 ± 10%, effective halflife 2.5 ± 0.7 days. Whole body activity <1 MBq was reached 13 ± 4 days after application of 131I. Radiation exposure of cat owners was estimated as 1.97 Sv/MBq for adults. Conclusion: Radioiodine therapy of feline hyper-thyroidism is highly effective and safe. It can easily be performed in accordance with German radiation protection regulations, although this requires hospitalisation for approximately two weeks. Practical considerations on radiation exposure of cat owners do not justify this long interval. Regulations for the veterinary use of radioactive substances similar to existing regulations for medical use in humans are higly desirable.
Collapse
|
24
|
Steiner D, Puille M, Khalisi A, Matter HP, Stürz H, Bauer R, Klell R. Antigranulocyte scintigraphy of septic loosening of hip prosthesis: influence of different analyzing methods. Nuklearmedizin 2018. [DOI: 10.1055/s-0038-1623874] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Summary
Aim: Diagnosis of infection with help of antigranulocyte scintigraphy near body stem is difficult because of contemporary visualisation of bone marrow. Therefore, we investigated, whether it is possible to improve the accuracy in diagnosing septic loosening of hip endoprosthesis by changing the analyzing methods. Methods: In 28 patients, the results of a visual interpretation of late scan, a visual interpretation and a quantitative interpretation of time-activity-course were compared. These results were verified by histology respectively microbiology. Results: Histological and microbiological verification found 14 septic loosening and 14 aseptic loosening of the hip protheses. Therefore, sensitivity, specifity, negative and positive predictive value for the visual interpretation of late scan were 0.86,0.57,0.80 and 0.67. For visual and quantitative interpretation of time-activity-course we found 0.86,0.79,0.85 and 0.80 respectively 1,0.93, 1,0.93. For interobserver agreement we found kappa coefficients of 0.28 ± 0.2 for visual interpretation of late scan, 0.48 ±0.17 for visual interpretation and 1.0 ± 0 for quantitative interpretation of time-activity-course. Conclusion: In all investigated values quantitative interpretation of time-activity-course was superior to the other analyzing methods. Therefore, antigranulocyte scintigraphy for septic loosening of hip endoprosthesis should be interpreted quantitativly.
Collapse
|
25
|
Nikzad-Langerodi R, Ortmann S, Pferschy-Wenzig E, Bochkov V, Zhao Y, Miao J, Saukel J, Ladurner A, Heiss E, Dirsch V, Bauer R, Atanasov A. Assessment of anti-inflammatory properties of extracts from Honeysuckle (Lonicera sp. L., Caprifoliaceae) by ATR-FTIR spectroscopy. Talanta 2017; 175:264-272. [DOI: 10.1016/j.talanta.2017.07.045] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2017] [Revised: 07/11/2017] [Accepted: 07/14/2017] [Indexed: 12/16/2022]
|
26
|
Bauer M, Glenn T, Alda M, Aleksandrovich MA, Andreassen OA, Angelopoulos E, Ardau R, Ayhan Y, Baethge C, Bharathram SR, Bauer R, Baune BT, Becerra-Palars C, Bellivier F, Belmaker RH, Berk M, Bersudsky Y, Bicakci Ş, Birabwa-Oketcho H, Bjella TD, Bossini L, Cabrera J, Cheung EYW, Del Zompo M, Dodd S, Donix M, Etain B, Fagiolini A, Fountoulakis KN, Frye MA, Gonzalez-Pinto A, Gottlieb JF, Grof P, Harima H, Henry C, Isometsä ET, Janno S, Kapczinski F, Kardell M, Khaldi S, Kliwicki S, König B, Kot TL, Krogh R, Kunz M, Lafer B, Landén M, Larsen ER, Lewitzka U, Licht RW, Lopez-Jaramillo C, MacQueen G, Manchia M, Marsh W, Martinez-Cengotitabengoa M, Melle I, Meza-Urzúa F, Yee Ming M, Monteith S, Morken G, Mosca E, Munoz R, Mythri SV, Nacef F, Nadella RK, Nery FG, Nielsen RE, O'Donovan C, Omrani A, Osher Y, Østermark Sørensen H, Ouali U, Pica Ruiz Y, Pilhatsch M, Pinna M, da Ponte FDR, Quiroz D, Ramesar R, Rasgon N, Reddy MS, Reif A, Ritter P, Rybakowski JK, Sagduyu K, Scippa ÂM, Severus E, Simhandl C, Stein DJ, Strejilevich S, Subramaniam M, Sulaiman AH, Suominen K, Tagata H, Tatebayashi Y, Tondo L, Torrent C, Vaaler AE, Veeh J, Vieta E, Viswanath B, Yoldi-Negrete M, Zetin M, Zgueb Y, Whybrow PC. Solar insolation in springtime influences age of onset of bipolar I disorder. Acta Psychiatr Scand 2017; 136:571-582. [PMID: 28722128 DOI: 10.1111/acps.12772] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 06/16/2017] [Indexed: 01/19/2023]
Abstract
OBJECTIVE To confirm prior findings that the larger the maximum monthly increase in solar insolation in springtime, the younger the age of onset of bipolar disorder. METHOD Data were collected from 5536 patients at 50 sites in 32 countries on six continents. Onset occurred at 456 locations in 57 countries. Variables included solar insolation, birth-cohort, family history, polarity of first episode and country physician density. RESULTS There was a significant, inverse association between the maximum monthly increase in solar insolation at the onset location, and the age of onset. This effect was reduced in those without a family history of mood disorders and with a first episode of mania rather than depression. The maximum monthly increase occurred in springtime. The youngest birth-cohort had the youngest age of onset. All prior relationships were confirmed using both the entire sample, and only the youngest birth-cohort (all estimated coefficients P < 0.001). CONCLUSION A large increase in springtime solar insolation may impact the onset of bipolar disorder, especially with a family history of mood disorders. Recent societal changes that affect light exposure (LED lighting, mobile devices backlit with LEDs) may influence adaptability to a springtime circadian challenge.
Collapse
Affiliation(s)
- M Bauer
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - T Glenn
- ChronoRecord Association, Fullerton, CA, USA
| | - M Alda
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
| | | | - O A Andreassen
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - E Angelopoulos
- Department of Psychiatry, Medical School, Eginition Hospital, National and Capodistrian University of Athens, Athens, Greece
| | - R Ardau
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - Y Ayhan
- Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | - C Baethge
- Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany
| | | | - R Bauer
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - B T Baune
- Department of Psychiatry, School of Medicine, University of Adelaide, Adelaide, SA, Australia
| | - C Becerra-Palars
- National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico
| | - F Bellivier
- Psychiatry and Addiction Medicine, Assistance Publique - Hôpitaux de Paris, FondaMental Foundation, INSERM UMR-S1144, Denis Diderot University, René Descartes University, Paris, France
| | - R H Belmaker
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - M Berk
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Vic., Australia.,Department of Psychiatry, Orygen, the National Centre for Excellence in Youth Mental Health, the Centre for Youth Mental Health and the Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Vic., Australia
| | - Y Bersudsky
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - Ş Bicakci
- Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey
| | | | - T D Bjella
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - L Bossini
- Department of Molecular Medicine and Department of Mental Health (DAI), University of Siena and University of Siena Medical Center (AOUS), Siena, Italy
| | - J Cabrera
- Mood Disorders Clinic, Dr. Jose Horwitz Psychiatric Institute, Santiago de Chile, Chile
| | - E Y W Cheung
- Department of General Adult Psychiatry, Castle Peak Hospital, Tuen Mun, Hong Kong
| | - M Del Zompo
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - S Dodd
- IMPACT Strategic Research Centre, School of Medicine, Barwon Health, Deakin University, Geelong, Vic., Australia.,Department of Psychiatry, University of Melbourneo, Parkville, Vic, Australia
| | - M Donix
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - B Etain
- Psychiatry and Addiction Medicine, Assistance Publique - Hôpitaux de Paris, FondaMental Foundation, INSERM UMR-S1144, Denis Diderot University, René Descartes University, Paris, France
| | - A Fagiolini
- Department of Molecular Medicine and Department of Mental Health (DAI), University of Siena and University of Siena Medical Center (AOUS), Siena, Italy
| | - K N Fountoulakis
- Division of Neurosciences, 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - M A Frye
- Department of Psychiatry & Psychology, Mayo Clinic Depression Center, Mayo Clinic, Rochester, MN, USA
| | - A Gonzalez-Pinto
- Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - J F Gottlieb
- Department of Psychiatry, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
| | - P Grof
- Mood Disorders Center of Ottawa, University of Toronto, Toronto, ON, Canada
| | - H Harima
- Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan
| | - C Henry
- AP-HP, Hopitaux Universitaires Henri Mondor and INSERM U955 (IMRB) and Université Paris Est and Institut Pasteur, Unité Perception et Mémoire, Paris, France
| | - E T Isometsä
- Department of Psychiatry, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.,National Institute for Health and Welfare, Helsinki, Finland
| | - S Janno
- Department of Psychiatry, University of Tartu, Tartu, Estonia
| | - F Kapczinski
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - M Kardell
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
| | - S Khaldi
- Private practice, Tunis, Tunisia
| | - S Kliwicki
- Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
| | - B König
- BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria
| | - T L Kot
- Khanty-Mansiysk Clinical Psychoneurological Hospital, Khanty-Mansiysk, Russia
| | - R Krogh
- Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark
| | - M Kunz
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - B Lafer
- Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
| | - M Landén
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy, University of Gothenburg, Gothenburg and Mölndal, Sweden.,Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
| | - E R Larsen
- Department of Affective Disorders, Q, Mood Disorders Research Unit, Aarhus University Hospital, Aarhus, Denmark
| | - U Lewitzka
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - R W Licht
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.,Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - C Lopez-Jaramillo
- Mood Disorders Program, Hospital Universitario San Vicente Fundación, Research Group in Psychiatry, Department of Psychiatry, Faculty of Medicine, Universidad de Antioquia, Medellín, Colombia
| | - G MacQueen
- Department of Psychiatry, Faculty of Medicine, University of Calgary, Calgary, AB, Canada
| | - M Manchia
- Section of Psychiatry, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy
| | - W Marsh
- Department of Psychiatry, University of Massachusetts, Worcester, MA, USA
| | - M Martinez-Cengotitabengoa
- Department of Psychiatry, University Hospital of Alava, University of the Basque Country, CIBERSAM, Vitoria, Spain
| | - I Melle
- NORMENT - K.G. Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - F Meza-Urzúa
- National Institute of Psychiatry '"Ramón de la Fuente Muñiz", Mexico City, Mexico
| | - M Yee Ming
- Department of General Psychiatry, Mood Disorders Unit, Institute of Mental Health, Singapore City, Singapore
| | - S Monteith
- Traverse City Campus, Michigan State University College of Human Medicine, Traverse City, MI, USA
| | - G Morken
- Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway.,Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway
| | - E Mosca
- Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy
| | - R Munoz
- Department of Psychiatry, University of California San Diego, San Diego, CA, USA
| | - S V Mythri
- Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India
| | - F Nacef
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - R K Nadella
- Department of Psychiatry, NIMHANS, Bangalore, India
| | - F G Nery
- Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil
| | - R E Nielsen
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark.,Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
| | - C O'Donovan
- Department of Psychiatry, Dalhousie University, Halifax, NS, Canada
| | - A Omrani
- Tunisian Bipolar Forum, Érable Médical Cabinet 324, Tunis, Tunisia
| | - Y Osher
- Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
| | - H Østermark Sørensen
- Unit for Psychiatric Research, Aalborg University Hospital, Psychiatry, Aalborg, Denmark
| | - U Ouali
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - Y Pica Ruiz
- Hospital "Ángeles del Pedregal", Mexico City, Mexico
| | - M Pilhatsch
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - M Pinna
- Lucio Bini Mood Disorder Center, Cagliari, Italy
| | - F D R da Ponte
- Department of Psychiatry, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
| | - D Quiroz
- Deparment of Psychiatry, Diego Portales University, Santiago de Chile, Chile
| | - R Ramesar
- UCT/MRC Human Genetics Research Unit, Division of Human Genetics, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
| | - N Rasgon
- Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine, Palo Alto, CA, USA
| | - M S Reddy
- Asha Bipolar Clinic, Asha Hospital, Hyderabad, Telangana, India
| | - A Reif
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
| | - P Ritter
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - J K Rybakowski
- Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland
| | - K Sagduyu
- Department of Psychiatry, University of Missouri Kansas City School of Medicine, Kansas City, MO, USA
| | - Â M Scippa
- Department of Neuroscience and Mental Health, Federal University of Bahia, Salvador, Brazil
| | - E Severus
- Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
| | - C Simhandl
- BIPOLAR Zentrum Wiener Neustadt, Wiener Neustadt, Austria
| | - D J Stein
- Department of Psychiatry, MRC Unit on Risk & Resilience in Mental Disorders, University of Cape Town, Cape Town, South Africa
| | - S Strejilevich
- Bipolar Disorder Program, Neuroscience Institute, Favaloro University, Buenos Aires, Argentina
| | - M Subramaniam
- Research Division, Institute of Mental Health, Singapore City, Singapore
| | - A H Sulaiman
- Department of Psychological Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
| | - K Suominen
- Department of Social Services and Health Care, Psychiatry, City of Helsinki, Helsinki, Finland
| | - H Tagata
- Department of Psychiatry, Tokyo Metropolitan Matsuzawa Hospital, Setagaya, Tokyo, Japan
| | - Y Tatebayashi
- Schizophrenia & Affective Disorders Research Project, Tokyo Metropolitan Institute of Medical Science, Seatagaya, Tokyo, Japan
| | - L Tondo
- McLean Hospital-Harvard Medical School, Boston, MA, USA.,Mood Disorder Lucio Bini Centers, Cagliari e Roma, Italy
| | - C Torrent
- Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - A E Vaaler
- Department of Mental Health, Norwegian University of Science and Technology - NTNU, Trondheim, Norway.,Department of Psychiatry, St Olavs' University Hospital, Trondheim, Norway
| | - J Veeh
- Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt am Main, Frankfurt am Main, Germany
| | - E Vieta
- Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain
| | - B Viswanath
- Department of Psychiatry, NIMHANS, Bangalore, India
| | - M Yoldi-Negrete
- Consejo Nacional de Ciencia y Tecnología - Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, Mexico
| | - M Zetin
- Department of Psychology, Chapman University, Orange, CA, USA
| | - Y Zgueb
- Razi Hospital, Faculty of Medicine, University of Tunis-El Manar, Tunis, Tunisia
| | - P C Whybrow
- Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior University of California Los Angeles (UCLA), Los Angeles, CA, USA
| |
Collapse
|
27
|
Lyons R, Turner SL, Walters AM, Kisser R, Rogmans W, Larsen B, Valkenberg H, Bejko D, Bauer R, Steiner M, Ellsaesser G. Identifying injury related inequalities using data from the European Injury Data Base (IDB). Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- R Lyons
- Swansea University, Swansea, UK
| | | | | | | | | | - B Larsen
- National Institute of Public Health, Odense, Denmark
| | - H Valkenberg
- Consumer Safety Institute, Amsterdam, Netherlands
| | - D Bejko
- Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - R Bauer
- Austrian Road Safety Board, Vienna, Austria
| | - M Steiner
- Austrian Road Safety Board, Vienna, Austria
| | - G Ellsaesser
- State Office of Occupational Safety, Consumer Protection and Health, Brandenburg, Germany
| |
Collapse
|
28
|
Bauer R, Pérez K, Weijermars W, Bos N, Filtness A, Johannsen H, Pascal L, Nuyttens N, Olabarria M. Measuring the severity of road injuries in the EU. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.155] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- R Bauer
- Road Safety Board (KFV), Vienna, Austria
| | - K Pérez
- Road Safety Board (KFV), Barcelona, Spain
| | - W Weijermars
- Institute for Road Safety Research (SWOV), The Hague, Netherlands
| | - N Bos
- Institute for Road Safety Research (SWOV), The Hague, Netherlands
| | - A Filtness
- Transport Safety Research Centre, Loughborough University, Loughborough, UK
| | - H Johannsen
- Medical University of Hannover, Hannover, Germany
| | - L Pascal
- Institute of Science and Technology for Transport, development and Networks, Paris, Austria
| | - N Nuyttens
- Institute of Science and Technology for Transport, development and Networks, Paris, Austria
| | - M Olabarria
- Agència de Salut Pública de Barcelona (ASPB), Barcelona, Spain
| |
Collapse
|
29
|
Turner SL, Walters AM, Kisser R, Rogmans W, Larsen B, Valkenberg H, Bejko D, Bauer R, Steiner M, Ellsaesser G, Lyons R. Measuring the burden of injury across Europe. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | | | | | | | - B Larsen
- National Institute of Public Health, Odense, Denmark
| | - H Valkenberg
- Consumer Safety Institute, Amsterdam, Netherlands
| | - D Bejko
- Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - R Bauer
- Austrian Road Safety Board, Vienna, Austria
| | - M Steiner
- Austrian Road Safety Board, Vienna, Austria
| | - G Ellsaesser
- State Office of Occupational Safety, Consumer Protection and Health, Brandenburg, Germany
| | - R Lyons
- Swansea University, Swansea, UK
| |
Collapse
|
30
|
Bauer R, Steiner M, Kühnelt-Leddhin A, Lyons R, Turner S, Walters W, Larsen B, Valkenberg H, Bejko D, Ellsaesser G, Rogmans W, Kisser R. Scope and patterns of under-reporting of vulnerable road users in official road accident statistics. Eur J Public Health 2017. [DOI: 10.1093/eurpub/ckx187.653] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- R Bauer
- Austrian Road Safety Board (KFV), Vienna, Austria
| | - M Steiner
- Austrian Road Safety Board (KFV), Vienna, Austria
| | | | - R Lyons
- Public Health Wales NHS Trust, Swansea, UK
| | - S Turner
- Public Health Wales NHS Trust, Swansea, UK
| | - W Walters
- Public Health Wales NHS Trust, Swansea, UK
| | - B Larsen
- National Institute of Public Health, Copenhagen, Denmark
| | - H Valkenberg
- Consumer Safety Institute, Amsterdam, Netherlands
| | - D Bejko
- Luxembourg Institute of Health, Luxembourg, Luxembourg
| | - G Ellsaesser
- State Office of Occupational Safety, Consumer Protection and Health, Brandenburg, Potsdam, Germany
| | | | | |
Collapse
|
31
|
Yuk J, Isaac G, Nikles S, Wrona M, Bauer R. The Comprehensive Screening of Traditional Chinese Medicine Using a Novel LC/MS Informatics Platform. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608333] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- J Yuk
- Waters Corporation, Milford, United States
| | - G Isaac
- Waters Corporation, Milford, United States
| | - S Nikles
- Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Graz, Austria
| | - M Wrona
- Waters Corporation, Milford, United States
| | - R Bauer
- Institute of Pharmaceutical Sciences, Department of Pharmacognosy, University of Graz, Graz, Austria
| |
Collapse
|
32
|
Durchschein C, Kretschmer N, Rinner B, Deutsch A, Stallinger A, Huefner A, Bauer R. Cytotoxic effects of novel semisynthetic shikonin derivatives on melanoma cells. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- C Durchschein
- Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
| | - N Kretschmer
- Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
| | - B Rinner
- Core Facility Alternative Biomodels and Preclinical Imaging, Medical University of Graz, Graz, Austria
| | - A Deutsch
- Division of Hematology, Medical University of Graz, Graz, Austria
| | - A Stallinger
- Core Facility Alternative Biomodels and Preclinical Imaging, Medical University of Graz, Graz, Austria
| | - A Huefner
- Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria
| | - R Bauer
- Institute of Pharmaceutical Sciences, University of Graz, Graz, Austria
| |
Collapse
|
33
|
Pferschy-Wenzig EM, Roßmann A, Koskinen K, Ardjomand-Woelkart K, Meng G, Koch E, Moissl-Eichinger C, Bauer R. Interactions between hawthorn extract WS® 1442 and human intestinal microbiota in vitro. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- EM Pferschy-Wenzig
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed Graz, Krenngasse 37, 8010 Graz, Austria
| | - A Roßmann
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
| | - K Koskinen
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed Graz, Krenngasse 37, 8010 Graz, Austria
| | - K Ardjomand-Woelkart
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
| | - G Meng
- Dr. Willmar Schwabe GmbH & Co. KG, Willmar-Schwabe-Str. 4, 76227 Karlsruhe, Germany
| | - E Koch
- Dr. Willmar Schwabe GmbH & Co. KG, Willmar-Schwabe-Str. 4, 76227 Karlsruhe, Germany
| | - C Moissl-Eichinger
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed Graz, Krenngasse 37, 8010 Graz, Austria
| | - R Bauer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed Graz, Krenngasse 37, 8010 Graz, Austria
| |
Collapse
|
34
|
Kretschmer N, Deutsch A, Rinner B, Scheideler M, Bauer R. Comparative gene expression study in WM164 melanoma cells treated with dimethylacrylshikonin. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- N Kretschmer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Graz, Austria
| | - A Deutsch
- Division of Hematology, Medical University of Graz, Graz, Austria
| | - B Rinner
- Core Facility Alternative Biomodels and Preclinical Imaging, Medical University of Graz, Graz, Austria
| | - M Scheideler
- Institute for Diabetes and Cancer, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany
- Joint Heidelberg-IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany
- German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - R Bauer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Graz, Austria
| |
Collapse
|
35
|
Pferschy-Wenzig EM, Roßmann A, Koskinen K, Abdel-Aziz H, Moissl-Eichinger C, Bauer R. Metabolization of the herbal combination STW-5 by human gut microbiota in vitro. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608399] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- EM Pferschy-Wenzig
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - A Roßmann
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - K Koskinen
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - H Abdel-Aziz
- Medical & Clinical Affairs Phytomedicines, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Havelstr. 5, 64295 Darmstadt, Germany
| | - C Moissl-Eichinger
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - R Bauer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| |
Collapse
|
36
|
Pferschy-Wenzig EM, Koskinen K, Roßmann A, Ardjomand-Woelkart K, Moissl-Eichinger C, Bauer R. Combining LC-MS metabolomics and next generation sequencing to study the interactions between herbal medicines and human gut bacteria in-vitro. Am J Transl Res 2017. [DOI: 10.1055/s-0037-1608574] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- EM Pferschy-Wenzig
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - K Koskinen
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - A Roßmann
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
| | - K Ardjomand-Woelkart
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
| | - C Moissl-Eichinger
- Medical University Graz, Department of Internal Medicine, Stiftingtalstraße 24/3/40, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| | - R Bauer
- University of Graz, Institute of Pharmaceutical Sciences, Department of Pharmacognosy, Universitaetsplatz 4, 8010 Graz, Austria
- BioTechMed, Krenngasse 37, 8010 Graz, Austria
| |
Collapse
|
37
|
Siepen FAD, Bauer R, Voss A, Hein S, Aurich M, Riffel J, Mereles D, Röcken C, Buss SJ, Katus HA, Kristen AV. Predictors of survival stratification in patients with wild-type cardiac amyloidosis. Clin Res Cardiol 2017; 107:158-169. [DOI: 10.1007/s00392-017-1167-1] [Citation(s) in RCA: 44] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2017] [Accepted: 09/19/2017] [Indexed: 11/28/2022]
|
38
|
Wroblewski M, Bauer R, Cubas Córdova M, Udonta F, Ben-Batalla I, Legler K, Hauser C, Egberts J, Janning M, Velthaus J, Schulze C, Pantel K, Bokemeyer C, Loges S. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B. Nat Commun 2017; 8:269. [PMID: 28814715 PMCID: PMC5559596 DOI: 10.1038/s41467-017-00327-8] [Citation(s) in RCA: 52] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Accepted: 06/20/2017] [Indexed: 02/03/2023] Open
Abstract
Resistance towards VEGF-centered anti-angiogenic therapy still represents a substantial clinical challenge. We report here that mast cells alter the proliferative and organizational state of endothelial cells which reduces the efficacy of anti-angiogenic therapy. Consequently, absence of mast cells sensitizes tumor vessels for anti-angiogenic therapy in different tumor models. Mechanistically, anti-angiogenic therapy only initially reduces tumor vessel proliferation, however, this treatment effect was abrogated over time as a result of mast cell-mediated restimulation of angiogenesis. We show that mast cells secrete increased amounts of granzyme b upon therapy, which mobilizes pro-angiogenic laminin- and vitronectin-bound FGF-1 and GM-CSF from the tumor matrix. In addition, mast cells also diminish efficacy of anti-angiogenic therapy by secretion of FGF-2. These pro-angiogenic factors act beside the targeted VEGFA–VEGFR2-axis and reinduce endothelial cell proliferation and angiogenesis despite the presence of anti-angiogenic therapy. Importantly, inhibition of mast cell degranulation with cromolyn is able to improve efficacy of anti-angiogenic therapy. Thus, concomitant mast cell-targeting might lead to improved efficacy of anti-angiogenic therapy. Resistance towards VEGF-centered anti-angiogenic therapy is an important clinical challenge. Here, the authors show that mast cells mediate resistance to anti-angiogenetic inhibitors by altering the proliferative and organizational state of endothelial cells through mobilization of FGF-1 and GM-CSF from the tumor matrix and secretion of FGF-2.
Collapse
Affiliation(s)
- M Wroblewski
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - R Bauer
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - M Cubas Córdova
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - F Udonta
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - I Ben-Batalla
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - K Legler
- Division of Molecular Oncology, Institute for Experimental Cancer Research, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, 25105, Kiel, Germany.,Department of Gynecology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - C Hauser
- Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, 25105, Kiel, Germany
| | - J Egberts
- Department of General, Visceral-, Thoracic-, Transplantation- and Pediatric Surgery, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Arnold-Heller-Straße 3, 25105, Kiel, Germany
| | - M Janning
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - J Velthaus
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - C Schulze
- Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Falkenried 94, 20251, Hamburg, Germany
| | - K Pantel
- Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - C Bokemeyer
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany
| | - S Loges
- Department of Hematology and Oncology with Sections BMT and Pneumology, Hubertus Wald Tumorzentrum, University Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. .,Institute of Tumor Biology, Center of Experimental Medicine University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
| |
Collapse
|
39
|
Franz M, Gruen K, Betge S, Fritzenwanger M, Ndongson-Dongmo B, Bauer R, Berndt A, Schulze P, Jung C. P1657Pharmacological inhibition of arginase activity in a rat model of monocrotaline-induced pulmonary hypertension. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx502.p1657] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
40
|
Ndongson Dongmo B, Moltzau L, Andressen K, Baretta M, Ghigo A, Brodhun M, Hirsch E, Coldewey S, Bauer R, Levy F. P4477Pi3kgamma inhibition rescues mice from acute cardiac contractile dysfunction, acquired long QT syndrome (acLQTS) and sudden death caused by calcineurin inhibitors. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4477] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
41
|
|
42
|
Scholtz J, Wichmann J, Bennett D, Leithner D, Albrecht M, Bucher A, Bauer R, Vogl T, Bodelle B. Diagnostic accuracy for detection of intracranial hemorrhage using automatic tube current modulation and advanced modeled iterative reconstruction in unenhanced head single-energy and dual-energy CT. ROFO-FORTSCHR RONTG 2017. [DOI: 10.1055/s-0037-1600409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- J Scholtz
- Massachusetts General Hospital, Division of Cardiovascular Imaging, Boston
| | - J Wichmann
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - D Bennett
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - D Leithner
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - M Albrecht
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - A Bucher
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - R Bauer
- Kantonspital St. Gallen, Klinik für Radiologie und Nuklearmedizin, St. Gallen/Schweiz
| | - T Vogl
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| | - B Bodelle
- Universitätsklinikum Frankfurt, Institut für Diagnostische und Interventionelle Radiologie, Frankfurt/Main
| |
Collapse
|
43
|
Tzika ED, Tassis PD, Papatsiros VG, Pferschy-Wenzig EM, Siochu A, Bauer R, Alexopoulos C, Kyriakis SC, Franz C. Evaluation of in-feed larch sawdust anti-inflammatory effect in sows. Pol J Vet Sci 2017; 20:321-327. [PMID: 28865211 DOI: 10.1515/pjvs-2017-0039] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
The study aimed to investigate the possible anti-inflammatory activity of larch sawdust as feed supplement in lactating sows' diet and its possible effect on the prevalence of Postpartum Dysgalactia Syndrome under field conditions. In a Greek farrow-to-finish pig farm, fifteen sows were randomly and equally allocated to a negative control group (NC group), a positive control group (PC group), and a treatment group (LT group). The animals of the first two groups received 99% basic diet and 1% corn starch, while LT group animals received 99% basic diet and 1% larch sawdust. The whole trial period lasted 35 days (7 days prior to farrow - day of weaning). At parturition day, animals of the PC group received 2 ml of an anti-inflammatory drug intramuscularly (meloxicam, Metacam®, Boehringer Ingelheim Vetmedica), while the animals of both other groups, received 2 ml of normal saline. Results showed insignificant differences among experimental groups for parameters such as post-partum rectal temperature and piglets performance. On the contrary, a significant increase of mean milk lactation index was observed in LT and PC groups on the 4th day of lactation period, when compared with NC group (p=0.014). Additionally, mean IL-6 concentrations in blood in the LT group showed a tendency for reduction when compared with those found in NC, and insignificant difference (p>0.05) when compared with those observed in PC group 24 hours postpartum. Moreover, the respective TNFα mean level in the LT group at 24 and 72 hours after parturition was similar to that found in PC group, respectively) and significantly lower than that determined in the NC group (p=0.003, p=0.024. The results suggest a possible anti-inflammatory effect of larch sawdust in sows.
Collapse
Affiliation(s)
| | | | | | | | - A Siochu
- Microbiologist, Kazazi St 31,55133 Kalamaria
| | | | | | | | | |
Collapse
|
44
|
Sampaio J, Weiß M, Gadanho M, Bauer R. New taxa in the Tremellales:Bulleribasidium oberjochensegen. et sp. nov.,Papiliotrema bandoniigen. et sp. nov. andFibulobasidium murrhardtensesp. nov. Mycologia 2017. [DOI: 10.1080/15572536.2003.11833182] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- J.P. Sampaio
- Centro de Recursos Microbiológicos, Secção Autónoma de Biotecnologia, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
| | - M. Weiß
- Universität Tübingen, Institut für Biologie I, Lehrstuhl Spezielle Botanik und Mykologie, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| | - M. Gadanho
- Centro de Recursos Microbiológicos, Secção Autónoma de Biotecnologia, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
| | - R. Bauer
- Universität Tübingen, Institut für Biologie I, Lehrstuhl Spezielle Botanik und Mykologie, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| |
Collapse
|
45
|
Affiliation(s)
| | | | - B.T.M. Dentinger
- Department of Plant Biology, University of Minnesota, Saint Paul, Minnesota 55108
| | - R. Bauer
- Lehrstuhl Spezielle Botanik und Mykologie, Universität Tübingen, Auf der Morgenstelle 1, D-72076 Tübingen, Germany
| | - D.J. McLaughlin
- Department of Plant Biology, University of Minnesota, Saint Paul, Minnesota 55108
| |
Collapse
|
46
|
Lyons RA, Turner S, Rogmans W, Kisser R, Larsen B, Valkenberg H, Bejko D, Bauer R, Steiner M. The European injury data base: supporting injury research and policy across Europe. Eur J Public Health 2016. [DOI: 10.1093/eurpub/ckw168.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
47
|
Bauer R, Hiten F, Crouch A, Kossmann J, Burger B. Acrolein Dimer as a Marker for Direct Detection of Acrolein in Wine. ACTA ACUST UNITED AC 2016. [DOI: 10.21548/33-1-1308] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
48
|
|
49
|
Lewitzka U, Bauer R. [Erratum to: Suicide and euthanasia. Discourse on physician-assisted suicide]. Nervenarzt 2016; 87:1010-1011. [PMID: 27357452 DOI: 10.1007/s00115-016-0167-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Affiliation(s)
- U Lewitzka
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Deutschland.
| | - R Bauer
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Deutschland
| |
Collapse
|
50
|
Ali N, Gomes M, Bauer R, Brodesser S, Niemann C, Iden S. 090 Essential role of polarity protein Par3 for epidermal homeostasis through regulation of barrier function, keratinocyte differentiation and stem cell maintenance. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.06.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|